| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations.
|
Lancet
|
2013
|
5.61
|
|
2
|
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.
|
Nat Biotechnol
|
2009
|
3.78
|
|
3
|
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
|
J Am Coll Cardiol
|
2010
|
3.21
|
|
4
|
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association.
|
Circulation
|
2005
|
1.97
|
|
5
|
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
|
JACC Cardiovasc Imaging
|
2009
|
1.92
|
|
6
|
Atherosclerosis in ancient Egyptian mummies: the Horus study.
|
JACC Cardiovasc Imaging
|
2011
|
1.83
|
|
7
|
Assessing the need for nuclear cardiology and other advanced cardiac imaging modalities in the developing world.
|
J Nucl Cardiol
|
2009
|
1.73
|
|
8
|
Computed tomographic assessment of atherosclerosis in ancient Egyptian mummies.
|
JAMA
|
2009
|
1.67
|
|
9
|
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging.
|
J Nucl Cardiol
|
2012
|
1.51
|
|
10
|
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
|
J Nucl Cardiol
|
2014
|
1.45
|
|
11
|
Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling.
|
Nucleic Acid Ther
|
2011
|
1.16
|
|
12
|
TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis.
|
Mol Cell Biol
|
2008
|
1.00
|
|
13
|
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.
|
J Virol
|
2008
|
0.99
|
|
14
|
TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells.
|
J Mol Biol
|
2009
|
0.90
|
|
15
|
Biological and analytical stability of a peripheral blood gene expression score for obstructive coronary artery disease in the PREDICT and COMPASS studies.
|
J Cardiovasc Transl Res
|
2014
|
0.88
|
|
16
|
Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise.
|
J Nucl Cardiol
|
2012
|
0.83
|
|
17
|
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy.
|
Thromb Haemost
|
2014
|
0.80
|
|
18
|
President's message: The global burden of cardiovascular disease.
|
J Nucl Cardiol
|
2007
|
0.79
|
|
19
|
The time and place for appropriate radionuclide imaging: now and everywhere.
|
J Nucl Cardiol
|
2011
|
0.79
|
|
20
|
Something old, something new--computed tomography studies of the cardiovascular system in ancient Egyptian mummies.
|
Am Heart Hosp J
|
2010
|
0.77
|
|
21
|
Pharmacologic stress myocardial perfusion imaging: a practical approach.
|
J Nucl Cardiol
|
2007
|
0.77
|
|
22
|
Atherosclerotic cardiovascular disease in Egyptian women: 1570 BCE-2011 CE.
|
Int J Cardiol
|
2012
|
0.76
|
|
23
|
Clinical imaging for prevention: directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis--Part I: Clinical imaging for prevention.
|
J Nucl Cardiol
|
2008
|
0.75
|
|
24
|
Is a revision of the "nuclear cardiology warranty" in order?
|
J Nucl Cardiol
|
2003
|
0.75
|
|
25
|
Advanced hybrid stress testing: a potential new paradigm combining exercise and pharmacologic stress.
|
J Nucl Cardiol
|
2012
|
0.75
|
|
26
|
Intersecting techniques: the evaluation of left ventricular function with cardiac computed tomography and myocardial perfusion imaging.
|
J Nucl Cardiol
|
2008
|
0.75
|
|
27
|
Potential indications for coronary angiography by computed tomography.
|
Am Heart Hosp J
|
2005
|
0.75
|
|
28
|
iPhone apps for heterozygous familial hypercholesterolemia.
|
J Clin Lipidol
|
2013
|
0.75
|
|
29
|
Virtual colonoscopy to screen for colorectal cancer.
|
N Engl J Med
|
2004
|
0.75
|
|
30
|
What to do with an equivocal myocardial perfusion study?
|
J Nucl Cardiol
|
2009
|
0.75
|
|
31
|
Atherosclerosis in ancient populations - Authors' reply.
|
Lancet
|
2013
|
0.75
|
|
32
|
Coronary computed tomographic angiography: competitive or complementary?
|
J Nucl Cardiol
|
2006
|
0.75
|
|
33
|
Regadenoson and exercise myocardial perfusion imaging: the courtship continues.
|
J Nucl Cardiol
|
2013
|
0.75
|
|
34
|
Myocardial perfusion imaging in hypertrophic cardiomyopathy.
|
Am Heart Hosp J
|
2010
|
0.75
|
|
35
|
Highlights of the 2007 scientific sessions of the American Society of Nuclear Cardiology San Diego, California, September 6-9, 2007.
|
J Am Coll Cardiol
|
2007
|
0.75
|
|
36
|
Role of computed tomography and perfusion imaging in patients with known or suspected coronary artery disease.
|
J Nucl Cardiol
|
2006
|
0.75
|
|
37
|
Minimally Invasive Aortic Valve Replacement via Right Anterior Minithoracotomy and Central Aortic Cannulation: A 13-Year Experience.
|
Innovations (Phila)
|
2017
|
0.75
|
|
38
|
An example of the clinical selectivity of regadenoson for the A2a adenosine receptor.
|
Am Heart Hosp J
|
2009
|
0.75
|
|
39
|
Delayed heart rate recovery after adenosine stress testing with supplemental arm exercise predicts mortality.
|
J Nucl Cardiol
|
2009
|
0.75
|
|
40
|
Indications and reimbursement of cardiac computed tomography angiography: history, present and future perspectives.
|
J Cardiovasc Comput Tomogr
|
2007
|
0.75
|
|
41
|
Morbid obesity and myocardial perfusion imaging.
|
Am Heart Hosp J
|
2007
|
0.75
|
|
42
|
Challenges and strategies in the provision of high-quality nuclear cardiology imaging services in office-based cardiology practice.
|
J Nucl Cardiol
|
2004
|
0.75
|